Mechanisms of Cancer

Content: 
This course covers the key molecular and cellular mechanisms involved in cancer development and progression, and addresses how our understanding of these mechanisms have impact on the development of novel therapeutic strategies.

With a focus on basic research, this one-week course covers selected aspects of the widely accepted “Hallmarks of cancers”, including genome instability and mutation, evasion of apoptosis, tissue invasion and metastasis, and avoidance of immune destruction, all presented by active researchers in the field. A variety of research strategies and technical issues will be presented along with examples from active research projects. Finally, emphasis will be given to the connection between basic cancer research and novel developments within targeted cancer therapy. This course is an improved and updated relaunch of a previous course (“Hallmarks of Cancer: course in tumor Biology”).

Format: 
Lectures, group discussions, clinical cases, and journal clubs.

Organizers:
Course director: Daniel Hargbøl Madsen, PhD, Junior Group Leader, Center for Cancer Immune Therapy, Herlev Hospital.

Kim Theilgaard-Mönch, MD DMSc, Assoc. Professor, Dept. of Hematology and The Finsen Laboratory, Rigshospitalet and Biotech Research and Innovation Centre, Univ. of Copenhagen.

Henrik Jessen Jürgensen, PhD, Postdoc, The Finsen Laboratory, Biotech Research and Innovation Centre, Univ. of Copenhagen.